Hong Kong To Review, Improve Drug-Regulation System
This article was originally published in PharmAsia News
Executive Summary
Hong Kong authorities are exploring improvements in the region's pharmaceutical system, particularly in existing regulations. Hong Kong's secretary for Food and Health told the Legislative Council that as a result of recent incidents involving pharmaceuticals, his agency and the Department of Health and Hospital Authority plan comprehensive steps to improve the system. Among regulations to be reviewed is the Good Manufacturing Practices requirement. The plan is to introduce risk-assessment principles and conduct microbiology testing. (Click here for more
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.